2-(Allylthio)pyrazine inhibition of aflatoxin B1-induced hepatocarcinogenesis in rats

Chemico-Biological Interactions

Volumn 121, Issue 2, 1999, Pages 209-222

  Ha, Tae Gil ^a   Jang, Ja June ^a   Kim, Sang Geon ^b   Kim, Nak Doo ^a  

^a Seoul National University   (South Korea)

^b Duksung Women's University   (South Korea)

Author keywords

2 (Allylthio)pyrazine; Aflatoxin B1; DNA adduct; Glutathione S transferase; Hepatocarcinogenesis; Placental form of glutathione S transferase

Indexed keywords

2 (ALLYLTHIO)PYRAZINE; AFLATOXIN B1; GLUTATHIONE TRANSFERASE; PHENOBARBITAL; PYRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; COVALENT BOND; DETOXIFICATION; DNA ADDUCT; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER CARCINOGENESIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; URINARY EXCRETION;

AFLATOXIN B1; ANIMALS; CARCINOGENICITY TESTS; DNA ADDUCTS; DNA, NEOPLASM; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; HEPATECTOMY; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PHENOBARBITAL; PRECANCEROUS CONDITIONS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; RNA;

ANIMALIA;

EID: 0032996538     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00094-0     Document Type: Article

References (33)

1. Kim N.D., Kwak M.K., Kim S.G. Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects. Biochem. Pharmacol. 53:1997;261-269.
2. Surh Y.-J., Kim S.G., Park K.K., Sohn Y.W., Lee J.-M., Kim N.D., Miller J.A. Chemopreventive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis, and tumorigenesis induced by vinyl carbamate or vinylcarbamate epoxide. Carcinogenesis. 19:1998;1263-3267.
3. S.G. Kim, M.K. Cho, S.H. Choi, H.J. Kim, M.K. Kwak, N.D. Kim, Molecular basis for hepatic detoxifying enzyme induction by 2-(allylthio)pyrazine in rats in comparison with oltipraz: effects on prooxidant production and DNA degradation, Drug Metab. Dispos. (1999) in press.
4. Kim N.D., Kim S.G., Kwak M.K. Enhanced expression of rat microsoal epoxide hydrolase gene by organosulfur compounds. Biochem. Pharmacol. 47:1994;541-547.
5. Kwak M.K., Lee W.I., Kim N.D., Lee M.G. Metabolic changes of acetaminophen after intravenous administration to rats pretreated with 2-(allythio)pyrazine. Biopharm. Drug Dispos. 19:1998;273-277.
6. Eaton D.L., Gallagher E.P. Mechanism of aflatoxin carcinogenesis. Annu. Rev. Pharamcol. Toxicol. 34:1994;135-172.
7. Miller E.C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 38:1978;479-496.
8. 1-DNA adduct formed in vivo in rat liver. Proc. Natl. Acad. Sci. USA. 75:1978;1745-1749.
9. 1 in vitro. Proc. Natl. Acad. Sci. USA. 74:1970;1870-1874.
10. 1-8,9 epoxide. Biochem. J. 279:1991;385-398.
11. 1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res. 51:1991;5501-5506.
12. 7-guanine and serum aflatoxin albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione. Carcinogenesis (Lond.). 13:1992;101-106.
13. Davidson N.E., Egner P.A., Kensler T.W. Transcriptional control of glutathione S-transferase gene expression by the chemopreventive agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res. 50:1990;2251-2255.
14. 1 biotranformation in rat liver: implications for human chemointervention. Cancer Res. 56:1996;2306-2313.
15. 1-induced hepatotoxicity and its covalent DNA binding in rats by inhibition of cytochrome P450 2B and 3A2. Res. Commun. Mol. Path. Pharmacol. 102:1998;69-78.
16. Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Masui T., Imaida K., Fukushima S., Asamoto M. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis. 9:1988;387-394.
17. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxydase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
18. 1 binding to DNA and biliary excretion of thiol conjugates in rats. Carcinogenesis. 8:1987;585-590.
19. Chomczynski P. Sacchi, Single-step method of RNA isoaltion by acid guanidinium thiocyanate-phenol-choroform extraction. Biotechniques. 8:1987;148-149.
20. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
22. 1-DNA adducts in healthy males. Carcinogenesis. 18:1997;1189-1194.
23. Kensler T.W., Groopman J.D., Eaton D.L., Curphey T.J., Roebucj B.D. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofuctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis. 13:1992;95-100.
24. 7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ. Health Perspect. 99:1993;107-113.
25. 1-treated rats. Cancer Res. 41:1981;650-654.
26. Sparnins V.L., Barany G., Wattenberg L. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis. 9:1998;131-134.
27. Hong J.-Y., Wang T.J., Smith S., Zhou S., Pan J., Yang C.S. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis. 13:1992;901-904.
28. Surh Y.-J., Lee R.C.-J., Park K.-K., Mayne S.T., Liem A., Miller J.A. Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinylcarbamate and N-nitrosodimethylamine. Carcinogenesis. 16:1995;2467-2471.
29. 1 metabolism in human hepatocytes in primary culture. Cancer Res. 55:1995;5574-5579.
30. Langouet S., Maheo K., Berthou F., Morel F., Lagadic-Gossman D., Glaise D., Coles B., Ketterer B., Guillouzo A. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Carcinogenesis. 18:1997;1343-1349.
31. Brady J.F., Ishizaki H., Fukuto J.M., Lin M.C., Fadel A., Gape J.M., Yang C.S. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol. 4:1991;642-647.
32. Primiano T., Egner P.E., Sutter T.R., Kelloff G.J., Roebuck B.D., Kensler T.W. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res. 44:1995;4319-4324.
33. 1 binding to exogenous and endogenous DNA by cytosolic glutathione S-transferases in rat and hamster livers. Carcinogenesis. 5:1984;269-276.